# Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

> **NCT00968630** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 9 (actual)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- HIV Infection

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Leukapheresis

## Key facts

- **NCT ID:** NCT00968630
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-17
- **Primary completion:** 2017-03-17
- **Final completion:** 2017-03-17
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-05-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968630, "Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00968630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*